Sun Pharma introduces Ilumya in India for treatment of moderate-to-severe plaque psoriasis: Our Bureau, Mumbai Tuesday, December 2, 2025, 14:45 Hrs [IST] Sun Pharma has announced ...

North America and Western Europe — two wealthier regions of the world — reported the highest incidences and are projected to ...

“Our study demonstrated in a large real-world population that long-term treatment of up to 5 years with adalimumab in adult patients with psoriasis led to a sustained improvement in the practice of ...

In patients with hidradenitis suppurativa, researchers discovered evidence that hormone-disrupting chemicals commonly found ...

Mumbai-based Sun Pharma has introduced its global innovative biologic Ilumya (Tildrakizumab) in India for the treatment of moderate-to-seve.

Researchers in China report that global incidence rates of psoriasis rose slightly from 1990 to 2021 and are projected to ...

The cost of 15 prescription drugs – including super-popular medications used for weight loss – will be lowered following ...